Bipolar disorder, also known as manic depression, is a type of mental health condition which is associated with mood swings. Mood swings/ episodes are of two types: manic and depressive. The changes in the mental health causes sudden high or low moods in a person. A person suffering from bipolar disorder or maniac depression can be joyful, happy, and energized or sad and hopeless at the very next moment. Through rigorous research and development activities, scientists have discovered that certain genes cause the bipolar disorder. Family history of bipolar disorder is one of the major reason that causes such illness. Such kind of mood swings can spoil the image of the person at a school or work place or in the society.
MARKET DYNAMICS
Growing awareness about diagnosis and treatment of bipolar disorder, increasing acceptance of society regarding mental illness, technological advancement bipolar disorder diagnosis and increase in treatment options for genetic disorders are major factors driving the bipolar disorder treatment market. Furthermore, government initiatives such as launch of Bipolar Disorder Phenome Database, funded by the National Institute of Mental Health (NIMH). These factors has further contributed to the growth of the market. However, factors such as stringent regulatory frameworks, side effects of anticonvulsants, and limited number of approved anticonvulsants for the treatment are few factors may restrain the growth of the market.
MARKET SCOPE
The "Global Bipolar Disorders Treatment Market Analysis to 2028" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of Bipolar Disorders Treatment market with detailed market segmentation by type, medication, treatment and geography. The global Bipolar Disorders Treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Bipolar Disorders Treatment market players and offers key trends and opportunities in the market.
MARKET SEGMENTATION
The global Bipolar Disorders Treatment market is segmented on the type, medication and treatment. On the basis of type, the global Bipolar Disorders Treatment market is segmented into Bipolar I, Bipolar II and Cyclothymia. On the basis of medication, the market is segmented into lithium, anticonvulsants, antipsychotics, antidepressants and anti-anxiety medications. On the basis of treatment, the bipolar disorder treatment market is segmented into ECT (Electroconvulsive therapy), TMS (Transcranial magnetic stimulation) and others (Psychotic therapies).
(image)
REGIONAL FRAMEWORKThe report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Bipolar Disorders Treatment market based on various segments. It also provides market size and forecast estimates from year 2020 to 2028 with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The Bipolar Disorders Treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
The report analyzes factors affecting Bipolar Disorders Treatment market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Bipolar Disorders Treatment market in these regions.
(image)
MARKET PLAYERSThe reports cover key developments in the Bipolar Disorders Treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies activities witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from Bipolar Disorders Treatment market are anticipated to lucrative growth opportunities in the future with the rising demand for Bipolar Disorders Treatment in the global market. Below mentioned is the list of few companies engaged in the Bipolar Disorders Treatment market.
The report also includes the profiles of key Bipolar Disorders Treatment market companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years.
-AbbVie Inc.
-AstraZeneca
-Allergan Plc.
-Bristol-Myers Squibb
-Eli Lilly and Company
-GlaxoSmithKline
-Janssen Pharmaceuticals
-Merck & Co., Inc.
-Novartis AG
-Pfizer Inc.
-Otsuka Holdings Co. Ltd.
(image)